These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36669330)

  • 1. Systematic engineering of virus-like particles to identify self-assembly rules for shifting particle size.
    Ikwuagwu B; Hartman E; Mills CE; Tullman-Ercek D
    Virology; 2023 Feb; 579():137-147. PubMed ID: 36669330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies.
    Guo Y; Guo R; Ma Y; Chang W; Ming S; Yang G; Guo Y
    Curr Top Med Chem; 2021 Oct; 21(14):1235-1250. PubMed ID: 34145995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape.
    Robinson SA; Hartman EC; Ikwuagwu BC; Francis MB; Tullman-Ercek D
    Biomacromolecules; 2020 Oct; 21(10):4194-4204. PubMed ID: 32880435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
    Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
    Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data.
    Liekniņa I; Kalniņš G; Akopjana I; Bogans J; Šišovs M; Jansons J; Rūmnieks J; Tārs K
    J Nanobiotechnology; 2019 May; 17(1):61. PubMed ID: 31084612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.
    Lagoutte P; Mignon C; Donnat S; Stadthagen G; Mast J; Sodoyer R; Lugari A; Werle B
    J Virol Methods; 2016 Jun; 232():8-11. PubMed ID: 26947397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast-expressed bacteriophage-like particles for the packaging of nanomaterials.
    Freivalds J; Kotelovica S; Voronkova T; Ose V; Tars K; Kazaks A
    Mol Biotechnol; 2014 Feb; 56(2):102-10. PubMed ID: 23852987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic.
    Lu W; Zhao Z; Huang YW; Wang B
    Int J Biol Macromol; 2022 Mar; 200():487-497. PubMed ID: 35065135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.
    Meshram CD; Baviskar PS; Ognibene CM; Oomens AGP
    J Virol; 2016 Dec; 90(23):10612-10628. PubMed ID: 27654298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitness Landscape-Guided Engineering of Locally Supercharged Virus-like Particles with Enhanced Cell Uptake Properties.
    Pistono PE; Huang P; Brauer DD; Francis MB
    ACS Chem Biol; 2022 Dec; 17(12):3367-3378. PubMed ID: 36378277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS2 Virus-like Particles as a Versatile Peptide Presentation Platform: Insights into the Deterministic Abilities for Accommodating Heterologous Peptide Lengths.
    Dang M; Wu LJ; Zhang SR; Zhu JR; Hu YZ; Yang CX; Zhang XY
    ACS Synth Biol; 2023 Dec; 12(12):3704-3715. PubMed ID: 37946498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage Qβ virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus.
    Basu R; Zhai L; Rosso B; Tumban E
    Vaccine; 2020 Mar; 38(11):2542-2550. PubMed ID: 32044164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and Application of Insect Virus-Based VLPs.
    Gopal R; Schneemann A
    Methods Mol Biol; 2018; 1776():125-141. PubMed ID: 29869238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the synthesis and purification of MS2 virus like particles.
    Hashemi K; Ghahramani Seno MM; Ahmadian MR; Malaekeh-Nikouei B; Bassami MR; Dehghani H; Afkhami-Goli A
    Sci Rep; 2021 Oct; 11(1):19851. PubMed ID: 34615923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.
    O'Rourke JP; Peabody DS; Chackerian B
    Curr Opin Virol; 2015 Apr; 11():76-82. PubMed ID: 25829254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ssRNA phage VLP platform for displaying foreign epitopes by genetic fusion.
    Liekniņa I; Černova D; Rūmnieks J; Tārs K
    Vaccine; 2020 Aug; 38(38):6019-6026. PubMed ID: 32713683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative analysis of nine types of virus-like particles in human papilloma virus bulk by size-exclusion chromatography].
    Long Z; Li X; Li X; Liu J; Nie J; Li C; Li Y; Huang T; Huang W
    Se Pu; 2021 Apr; 39(4):424-429. PubMed ID: 34227763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.